Skip to main content
Equibles

EARNEST PARTNERS LLC

Position in NVS — Novartis AG

CIK 1102578 ATLANTA, GA
Back to NVS Full portfolio

Position in NVS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$138,953,280
+$3,725,233 QoQ
Shares Held
886,634
+0.2% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 80% Shared 0% None 20%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

EARNEST PARTNERS LLC holds $139,876,807 across 4 Drug Manufacturers - General names. NVS ranks #1 (99.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NVS
Novartis AG
This page 		886,634 $138,953,280
2 LLY
ELI LILLY & Co
 399 $478,572
3 JNJ
Johnson & Johnson
 888 $225,525
4 ABBV
AbbVie Inc.
 872 $219,430

All Filings in NVS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $138,953,280 886,634
2026-03-31 $135,228,047 885,290
2025-12-31 $127,032,866 921,396
2025-09-30 $107,724,934 840,026
2025-06-30 $102,883,549 850,207
2025-03-31 $91,900,879 824,371
2024-12-31 $77,450,099 795,911
2024-09-30 $93,068,087 809,147
2024-06-30 $86,156,694 809,287
2024-03-31 $80,822,848 835,551
2023-12-31 $82,191,195 814,016
2023-09-30 $83,101,258 815,838
2023-06-30 $84,765,207 840,008
2023-03-31 $78,270,104 850,762
2022-12-31 $77,754,025 857,077
2022-09-30 $66,259,285 871,718
2022-06-30 $73,281,931 866,934
2022-03-31 $78,406,906 893,526
2021-12-31 $79,144,430 904,818
2021-09-30 $77,054,097 942,212
2021-06-30 $90,806,518 995,249
2021-03-31 $91,667,127 1,072,381
2020-12-31 $93,742,832 992,723
2020-09-30 $84,530,511 972,062
2020-06-30 $86,517,257 990,580
2020-03-31 $109,891,091 1,332,821